Fewer Major Adverse Cardiovascular Events With New Antihyperglycemic Drugs With Lower Hypoglycemic Risk
Thiazolidinediones, DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT2 inhibitors were examined in the meta-analysis.
Huang C-J, Want W-T, Sung S-H, et al. Blood glucose reduction by diabetic drugs with minimal hypoglycemia risk for cardiovascular outcomes: evidence from meta-regression analysis of randomized controlled trials [published online May 2, 2018]. Diabetes Obes Metab. doi: 10.1111/dom.13342